Oruka Therapeutics, Inc. (ORKA) earnings
ORKA earnings moved a median of +0.85% by the close. Quarterly and annual ORKA reports and results, each read against the price at its own news timestamp. Back to the ORKA overview →
15 measured ORKA earnings events.
Where these ORKA earnings landedvs 10 measured ORKA earnings reactions
| Middle 50% of ORKA earnings reactions | -3.58% to +5.15% |
|---|---|
| Median reaction (to close) | +0.85% |
| Measured reactions | 10 |
Point-in-time · zero look-ahead
Half of the 10 ORKA earnings events with a measured close landed between -3.58% and +5.15%; 60% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Oruka Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.61% | +5.27% | |
| Oruka Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update | Press release | -0.61% | +5.27% | |
| Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Press release | — | — | |
| Form 10-Q Oruka Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.85% | +0.85% | |
| Oruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | Press release | -0.85% | +0.85% | |
| Form 10-K Oruka Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +4.35% | +21.80% | |
| Form 10-Q Oruka Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -6.48% | — | |
| Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | -6.48% | — | |
| Form 10-Q Oruka Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.57% | — | |
| Oruka Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | -0.57% | — | |
| Form 10-Q Oruka Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -7.05% | -9.82% | |
| Oruka Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update | Press release | -7.05% | -9.82% | |
| Form 10-K Oruka Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -2.60% | +4.81% | |
| Form 10-Q Oruka Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +10.08% | -3.58% | |
| Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update | Press release | +10.08% | -3.58% |
Keep exploring
More ORKA: analyst actions → · SEC filings → · ORKA overview →